Abstract

BackgroundThe demand in biobanking for the collection and maintenance of biological specimens and personal data from civilians to improve the prevention, diagnosis and treatment of diseases has increased notably. Despite the advancement, certain issues, specifically those related to privacy and data protection, have been critically discussed. The purposes of this study are to assess the willingness of stakeholders to participate in biobanking and to determine its predictors.MethodsA survey of 469 respondents from various stakeholder groups in the Klang Valley region of Malaysia was carried out. Based on previous research, a multi-dimensional instrument measuring willingness to participate in biobanking, and its predictors, was constructed and validated. A single step Structural Equation Modelling was performed to analyse the measurements and structural model using the International Business Machines Corporation Software Package for Social Sciences, Analysis of Moment Structures (IBM SPSS Amos) version 20 with a maximum likelihood function.ResultsMalaysian stakeholders in the Klang Valley were found to be cautious of biobanks. Although they perceived the biobanks as moderately beneficial (mean score of 4.65) and were moderately willing to participate in biobanking (mean score of 4.10), they professed moderate concern about data and specimen protection issues (mean score of 4.33). Willingness to participate in biobanking was predominantly determined by four direct predictors: specific application-linked perceptions of their benefits (β = 0.35, p < 0.001), issues of data and specimen protection (β = − 0.31, p < 0.001) and religious acceptance (β = 0.15, p < 0.05) and trust in key players (β = 0.20, p < 0.001). The stakeholders’ willingness to participate in biobanking also involves the intricate relationships between the above-mentioned factors and other predictors, such as attitudes regarding technology, religiosity and engagement.ConclusionsThe findings of this study reaffirmed that stakeholders’ willingness to participate in biobanking is a complex phenomenon that should be viewed from a multidimensional perspective. Stakeholder willingness to participate in biobanking is warranted when direct predictors (benefits, issues of data and specimen protection, religious acceptance, and trust in key players) as well as indirect factors are well accounted for.

Highlights

  • The demand in biobanking for the collection and maintenance of biological specimens and personal data from civilians to improve the prevention, diagnosis and treatment of diseases has increased notably

  • Trust in key players came out third as a direct predictor of stakeholders’ support for and participation in biobanking (β = 0.20, p < 0.001) (Fig. 2). This result shows that when Malaysian stakeholders in the Klang Valley have more trust in key players involved in modern biotechnology product development or its regulation, they will be more willing to participate in biobanking

  • Despite moderate concerns relating to biobank issues, the mean score for the variable was found to be much lower than the perceived benefits, translating into a moderate willingness to participate in biobanking overall

Read more

Summary

Introduction

The demand in biobanking for the collection and maintenance of biological specimens and personal data from civilians to improve the prevention, diagnosis and treatment of diseases has increased notably. In Malaysia, the first biobank initiative known as “The Malaysian Cohort” was approved by the Malaysian cabinet in 2005 It involves the operation of a rich database of information and biospecimens that serves as a platform for studying the roles and interactions of genes, the environment and lifestyle patterns [4]. Through this effort, comprehensive human samples have been collected from more than 100,000 donors in Malaysia. Approximately another 39 assisted reproductive technology (ART) clinics and several tissue-specific-based biobanks have been established [5]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call